Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Comorbidity is associated with pain-related activity limitations in multiple sclerosis.
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS).
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Peripartum depression in parents with multiple sclerosis and psychiatric disorders in children.
Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes.
Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods.
Sex Chromosome Complement Influences Functional Callosal Myelination.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Sonic hedgehog promotes generation and maintenance of human forebrain Olig2 progenitors.
The incidence and prevalence of neuromyelitis optica: a systematic review.
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice.
Acute Bilateral Optic Neuritis in Active Ankylosing Spondylitis.
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
Gamma Knife rhizotomy-induced histopathology in multiple sclerosis-related trigeminal neuralgia.
Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.
Multiple sclerosis in Japan appears to be a milder disease compared to the UK.
Th17 cells in autoimmune diseases.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
Alarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses.
Remyelination therapy goes to trial for multiple sclerosis.
Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
Increased Circulating Levels of Vitamin D Binding Protein in MS Patients.
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases.

Pages